Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

GenVec Inc - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 14/12/2007
  • Report Title: GenVec Inc - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 53
Introduction

GenVec is a clinical-stage biopharmaceutical company utilizes its proprietary platform, adenovector technology. It's collaborations with National Institute of Health, US Navy and US Department of Agriculture to use its delivery platform to develop vaccines against HIV, influenza, malaria, and foot and mouth disease have established it as potential player in Vaccine market.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    GenVec is a clinical-stage biopharmaceutical company that specializes in using adenovector-based vectors to deliver gene-based therapies for the treatment of various cancers, including pancreatic, head and neck, and rectal cancer.The company's lead candidate, TNFerade, is in Phase II/III clinical trial for the treatment of pancreatic cancer.

    The key elements of the company's business strategy include: advancing the clinical development of its product candidate, TNFerade; continue application of its proprietary adenovector technology to develop new products and strengthening the company's financial and market position through its funded vaccine programs.

    The company's total revenues increased at a CAGR of 22.5% during 2002-2006, from $8.4 million to $18.9 million. This represents an absolute total growth of +$10.5 million for total revenues. The company's only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    English Italian Spanish French German Russian Chinese Arabic